Find Comparable Stocks for Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc.
ZBH - NYQZimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
Income Statement
Financial Ratios
Growth
Stryker Corporation
SYK - NYQStryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Zimmer Biomet Holdings focuses on musculoskeletal healthcare, providing products similar to Stryker, especially in joint replacement and surgical instruments, making it a direct competitor in the medical technology space.
correlation
Measures how closely the two stocks' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 41%
R-squared: 17%
This indicates a weak positive relationship between the price movements of these stocks.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 6
- SYK in ZBH's comparables: Yes
- ZBH in SYK's comparables: Yes
A high score suggests the companies are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
financials
Compares key financial metrics to assess operational similarity and financial health.
- Revenue Growth: 11% vs 4%
- Profit Margin: 13% vs 12%
- ROE: 15% vs 7%
- Operating Margin: 26% vs 23%
- Revenue (TTM): $22.6B vs $7.7B
A high score indicates similar financial performance, efficiency, and growth trajectories, suggesting comparable business models and market positions.
size
Evaluates similarity in market capitalization, which can indicate comparable market influence, investor interest, and resource availability.
Market Cap: $144.7B vs $21.5B
Size Category: Large Cap vs Large Cap
A high score suggests the companies are in the same size category, facing similar challenges and opportunities in terms of market presence and financial flexibility.
valuation
Compares valuation metrics to assess if the stocks are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.
- P/E Ratio: 48.75 vs 24.38
- P/B Ratio: 7.07 vs 1.72
- EV/EBITDA: 27.11 vs 12.07
- Forward P/E: 28.25 vs 13.14
- PEG Ratio: 2.82 vs 1.48
A high score indicates that the market values these companies similarly relative to their financials, suggesting comparable growth expectations and risk profiles.
sector
Compares the sector and industry classification of both companies, allowing for partial matches.
- Sector: LIFE SCIENCES vs LIFE SCIENCES
- Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS vs ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
A high score indicates that the companies operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends. Partial matches are considered for more nuanced comparisons.
analyst ratings
Compares the consensus of analyst opinions on both stocks.
- SYK Rating: Buy
- ZBH Rating: Hold
A high score suggests that analysts view both stocks similarly in terms of their future prospects and investment potential.
geo
Evaluates the geographical similarity of the companies based on country, currency, exchange, and address.
- SYK Country: USA
- ZBH Country: USA
- Currency: USD vs USD
- Exchange: NYQ vs NYQ
A high score indicates that both companies operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- SYK Beta: 0.96 (Average)
- ZBH Beta: 1.04 (Average)
A high score suggests both stocks have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
business similarity
Assesses the similarity of the companies' business models, products, and services.
This score is based on an analysis of the companies' business descriptions, major products, and revenue streams.
A high score indicates that the companies have similar core businesses, target markets, and revenue generation strategies.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- SYK Price vs 200-day MA: 104.97%
- ZBH Price vs 200-day MA: 99.85%
A high score indicates both stocks are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- SYK Dividend Yield: 1%
- ZBH Dividend Yield: 1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
Income Statement
Financial Ratios
Growth
Abbott Laboratories
ABT - NYQAbbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Abbott Laboratories operates in the medical device space and also has a focus on diagnostics and nutrition, which aligns with Zimmer Biomet's healthcare sector emphasis. Both companies are involved in innovative healthcare solutions.
correlation
Measures how closely the two stocks' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 42%
R-squared: 17%
This indicates a weak positive relationship between the price movements of these stocks.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 3
- ABT in ZBH's comparables: Yes
- ZBH in ABT's comparables: No
A high score suggests the companies are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
financials
Compares key financial metrics to assess operational similarity and financial health.
- Revenue Growth: 7% vs 4%
- Profit Margin: 32% vs 12%
- ROE: 31% vs 7%
- Operating Margin: 19% vs 23%
- Revenue (TTM): $41.9B vs $7.7B
A high score indicates similar financial performance, efficiency, and growth trajectories, suggesting comparable business models and market positions.
size
Evaluates similarity in market capitalization, which can indicate comparable market influence, investor interest, and resource availability.
Market Cap: $233.1B vs $21.5B
Size Category: Mega Cap vs Large Cap
A high score suggests the companies are in the same size category, facing similar challenges and opportunities in terms of market presence and financial flexibility.
valuation
Compares valuation metrics to assess if the stocks are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.
- P/E Ratio: 17.59 vs 24.38
- P/B Ratio: 5.01 vs 1.72
- EV/EBITDA: 22.77 vs 12.07
- Forward P/E: 26.74 vs 13.14
- PEG Ratio: 2.47 vs 1.48
A high score indicates that the market values these companies similarly relative to their financials, suggesting comparable growth expectations and risk profiles.
sector
Compares the sector and industry classification of both companies, allowing for partial matches.
- Sector: LIFE SCIENCES vs LIFE SCIENCES
- Industry: PHARMACEUTICAL PREPARATIONS vs ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
A high score indicates that the companies operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends. Partial matches are considered for more nuanced comparisons.
analyst ratings
Compares the consensus of analyst opinions on both stocks.
- ABT Rating: Buy
- ZBH Rating: Hold
A high score suggests that analysts view both stocks similarly in terms of their future prospects and investment potential.
geo
Evaluates the geographical similarity of the companies based on country, currency, exchange, and address.
- ABT Country: USA
- ZBH Country: USA
- Currency: USD vs USD
- Exchange: NYQ vs NYQ
A high score indicates that both companies operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- ABT Beta: 0.69 (Low)
- ZBH Beta: 1.04 (Average)
A high score suggests both stocks have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
business similarity
Assesses the similarity of the companies' business models, products, and services.
This score is based on an analysis of the companies' business descriptions, major products, and revenue streams.
A high score indicates that the companies have similar core businesses, target markets, and revenue generation strategies.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- ABT Price vs 200-day MA: 117.70%
- ZBH Price vs 200-day MA: 99.85%
A high score indicates both stocks are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- ABT Dividend Yield: 2%
- ZBH Dividend Yield: 1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
Income Statement
Financial Ratios
Growth
Medtronic plc
MDT - NYQMedtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Zimmer Biomet Holdings focuses on musculoskeletal healthcare and orthopedic products, positioning it similarly to Medtronic in the medical device industry with a focus on improving patient outcomes.
correlation
Measures how closely the two stocks' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 26%
R-squared: 7%
This indicates a negligible relationship between the price movements of these stocks.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 8
- MDT in ZBH's comparables: No
- ZBH in MDT's comparables: Yes
A high score suggests the companies are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
financials
Compares key financial metrics to assess operational similarity and financial health.
- Revenue Growth: 3% vs 4%
- Profit Margin: 13% vs 12%
- ROE: 8% vs 7%
- Operating Margin: 22% vs 23%
- Revenue (TTM): $33.2B vs $7.7B
A high score indicates similar financial performance, efficiency, and growth trajectories, suggesting comparable business models and market positions.
size
Evaluates similarity in market capitalization, which can indicate comparable market influence, investor interest, and resource availability.
Market Cap: $119.4B vs $21.5B
Size Category: Large Cap vs Large Cap
A high score suggests the companies are in the same size category, facing similar challenges and opportunities in terms of market presence and financial flexibility.
valuation
Compares valuation metrics to assess if the stocks are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.
- P/E Ratio: 28.39 vs 24.38
- P/B Ratio: 2.42 vs 1.72
- EV/EBITDA: 15.95 vs 12.07
- Forward P/E: 15.92 vs 13.14
- PEG Ratio: 1.89 vs 1.48
A high score indicates that the market values these companies similarly relative to their financials, suggesting comparable growth expectations and risk profiles.
sector
Compares the sector and industry classification of both companies, allowing for partial matches.
- Sector: LIFE SCIENCES vs LIFE SCIENCES
- Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS vs ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
A high score indicates that the companies operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends. Partial matches are considered for more nuanced comparisons.
analyst ratings
Compares the consensus of analyst opinions on both stocks.
- MDT Rating: Hold
- ZBH Rating: Hold
A high score suggests that analysts view both stocks similarly in terms of their future prospects and investment potential.
geo
Evaluates the geographical similarity of the companies based on country, currency, exchange, and address.
- MDT Country: USA
- ZBH Country: USA
- Currency: USD vs USD
- Exchange: NYQ vs NYQ
A high score indicates that both companies operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- MDT Beta: 0.82 (Low)
- ZBH Beta: 1.04 (Average)
A high score suggests both stocks have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
business similarity
Assesses the similarity of the companies' business models, products, and services.
This score is based on an analysis of the companies' business descriptions, major products, and revenue streams.
A high score indicates that the companies have similar core businesses, target markets, and revenue generation strategies.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- MDT Price vs 200-day MA: 108.86%
- ZBH Price vs 200-day MA: 99.85%
A high score indicates both stocks are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- MDT Dividend Yield: 3%
- ZBH Dividend Yield: 1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
Income Statement
Financial Ratios
Growth
Johnson & Johnson
JNJ - NYQJohnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Johnson & Johnson is a diversified healthcare giant with significant operations in medical devices, including orthopedic products. Its size and market presence provide a relevant benchmark for evaluating Zimmer Biomet's performance.
correlation
Measures how closely the two stocks' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 42%
R-squared: 18%
This indicates a weak positive relationship between the price movements of these stocks.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 3
- JNJ in ZBH's comparables: Yes
- ZBH in JNJ's comparables: No
A high score suggests the companies are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
financials
Compares key financial metrics to assess operational similarity and financial health.
- Revenue Growth: 5% vs 4%
- Profit Margin: 16% vs 12%
- ROE: 20% vs 7%
- Operating Margin: 18% vs 23%
- Revenue (TTM): $88.8B vs $7.7B
A high score indicates similar financial performance, efficiency, and growth trajectories, suggesting comparable business models and market positions.
size
Evaluates similarity in market capitalization, which can indicate comparable market influence, investor interest, and resource availability.
Market Cap: $397.3B vs $21.5B
Size Category: Mega Cap vs Large Cap
A high score suggests the companies are in the same size category, facing similar challenges and opportunities in terms of market presence and financial flexibility.
valuation
Compares valuation metrics to assess if the stocks are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.
- P/E Ratio: 28.50 vs 24.38
- P/B Ratio: 5.56 vs 1.72
- EV/EBITDA: 16.52 vs 12.07
- Forward P/E: 15.58 vs 13.14
- PEG Ratio: 1.12 vs 1.48
A high score indicates that the market values these companies similarly relative to their financials, suggesting comparable growth expectations and risk profiles.
sector
Compares the sector and industry classification of both companies, allowing for partial matches.
- Sector: LIFE SCIENCES vs LIFE SCIENCES
- Industry: PHARMACEUTICAL PREPARATIONS vs ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
A high score indicates that the companies operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends. Partial matches are considered for more nuanced comparisons.
analyst ratings
Compares the consensus of analyst opinions on both stocks.
- JNJ Rating: Buy
- ZBH Rating: Hold
A high score suggests that analysts view both stocks similarly in terms of their future prospects and investment potential.
geo
Evaluates the geographical similarity of the companies based on country, currency, exchange, and address.
- JNJ Country: USA
- ZBH Country: USA
- Currency: USD vs USD
- Exchange: NYQ vs NYQ
A high score indicates that both companies operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- JNJ Beta: 0.51 (Low)
- ZBH Beta: 1.04 (Average)
A high score suggests both stocks have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
business similarity
Assesses the similarity of the companies' business models, products, and services.
This score is based on an analysis of the companies' business descriptions, major products, and revenue streams.
A high score indicates that the companies have similar core businesses, target markets, and revenue generation strategies.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- JNJ Price vs 200-day MA: 106.67%
- ZBH Price vs 200-day MA: 99.85%
A high score indicates both stocks are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- JNJ Dividend Yield: 3%
- ZBH Dividend Yield: 1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
Income Statement
Financial Ratios
Growth
Solid Biosciences Inc.
SLDB - NMSSolid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. The company is headquartered in Cambridge, Massachusetts.
correlation
Measures how closely the two stocks' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 11%
R-squared: 1%
This indicates a negligible relationship between the price movements of these stocks.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 0
- SLDB in ZBH's comparables: No
- ZBH in SLDB's comparables: No
A high score suggests the companies are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
financials
Compares key financial metrics to assess operational similarity and financial health.
- Revenue Growth: -100% vs 4%
- Profit Margin: 0% vs 12%
- ROE: -95% vs 7%
- Operating Margin: 0% vs 23%
- Revenue (TTM): $0 vs $7.7B
A high score indicates similar financial performance, efficiency, and growth trajectories, suggesting comparable business models and market positions.
size
Evaluates similarity in market capitalization, which can indicate comparable market influence, investor interest, and resource availability.
Market Cap: $413.6M vs $21.5B
Size Category: Small Cap vs Large Cap
A high score suggests the companies are in the same size category, facing similar challenges and opportunities in terms of market presence and financial flexibility.
valuation
Compares valuation metrics to assess if the stocks are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.
- P/E Ratio: 0.00 vs 24.38
- P/B Ratio: 3.01 vs 1.72
- EV/EBITDA: -3.69 vs 12.07
- Forward P/E: 0.00 vs 13.14
- PEG Ratio: 0.00 vs 1.48
A high score indicates that the market values these companies similarly relative to their financials, suggesting comparable growth expectations and risk profiles.
sector
Compares the sector and industry classification of both companies, allowing for partial matches.
- Sector: LIFE SCIENCES vs LIFE SCIENCES
- Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) vs ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
A high score indicates that the companies operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends. Partial matches are considered for more nuanced comparisons.
analyst ratings
Compares the consensus of analyst opinions on both stocks.
- SLDB Rating: Buy
- ZBH Rating: Hold
A high score suggests that analysts view both stocks similarly in terms of their future prospects and investment potential.
geo
Evaluates the geographical similarity of the companies based on country, currency, exchange, and address.
- SLDB Country: USA
- ZBH Country: USA
- Currency: USD vs USD
- Exchange: NMS vs NYQ
A high score indicates that both companies operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- SLDB Beta: 1.98 (High)
- ZBH Beta: 1.04 (Average)
A high score suggests both stocks have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
business similarity
Assesses the similarity of the companies' business models, products, and services.
This score is based on an analysis of the companies' business descriptions, major products, and revenue streams.
A high score indicates that the companies have similar core businesses, target markets, and revenue generation strategies.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- SLDB Price vs 200-day MA: 86.17%
- ZBH Price vs 200-day MA: 99.85%
A high score indicates both stocks are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
Income Statement
Financial Ratios
Growth
Loading comparable stocks ...
Stryker Corporation
SYK - NYQStryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surg...
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Abbott Laboratories
ABT - NYQAbbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace...
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Medtronic plc
MDT - NYQMedtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the...
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Johnson & Johnson
JNJ - NYQJohnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow...
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Solid Biosciences Inc.
SLDB - NMSSolid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. The company is headquartered in Cambridge, Massachuset...
Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. The company is headquartered in Cambridge, Massachusetts.